DLL4 and neoplasm: A similar work demonstrated the anti-tumor role of Dll4 blockade in breast cancer mouse xenograft models, where combined treatment of anti-Dll4 antibody in combination with docetaxel led to tumor cell apoptosis, CSC phenotype and reversal of EMT (Xu Z. et al., 2016).